Home Other Building Blocks FARAMPATOR

FARAMPATOR

CAS No.:
211735-76-1
Catalog Number:
AG00C2EX
Molecular Formula:
C12H13N3O2
Molecular Weight:
231.2505
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$105
- +
5mg
99%
1 week
United States
$207
- +
10mg
99%
1 week
United States
$257
- +
25mg
99%
1 week
United States
$457
- +
50mg
99%
1 week
United States
$723
- +
100mg
99%
1 week
United States
$1257
- +
Product Description
Catalog Number:
AG00C2EX
Chemical Name:
FARAMPATOR
CAS Number:
211735-76-1
Molecular Formula:
C12H13N3O2
Molecular Weight:
231.2505
MDL Number:
MFCD00831010
IUPAC Name:
2,1,3-benzoxadiazol-5-yl(piperidin-1-yl)methanone
InChI:
InChI=1S/C12H13N3O2/c16-12(15-6-2-1-3-7-15)9-4-5-10-11(8-9)14-17-13-10/h4-5,8H,1-3,6-7H2
InChI Key:
XFVRBYKKGGDPAJ-UHFFFAOYSA-N
SMILES:
O=C(c1ccc2c(c1)non2)N1CCCCC1
UNII:
7X6P5N8K2L
Properties
Complexity:
292  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
231.101g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
231.255g/mol
Monoisotopic Mass:
231.101g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
59.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5  
Literature
Title Journal
Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission. Psychopharmacology 20120501
Glutamatergic targets for enhancing extinction learning in drug addiction. Current neuropharmacology 20101201
Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor. Journal of medicinal chemistry 20101028
Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat. Psychopharmacology 20090101
Current management of the cognitive dysfunction in Parkinson's disease: how far have we come? Experimental biology and medicine (Maywood, N.J.) 20080801
Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070601
Proceedings: Proton magnetic relaxation of some high spin hemoproteins in aqueous solutions. Israel journal of medical sciences 19751101
Properties